Literature DB >> 16455421

Effects of levosimendan on left ventricular diastolic function after primary angioplasty for acute anterior myocardial infarction: a Doppler echocardiographic study.

Leonardo De Luca1, Gennaro Sardella, Paola Proietti, Alessandro Battagliese, Giulia Benedetti, Angelo Di Roma, Francesco Fedele.   

Abstract

BACKGROUND: Levosimendan is a new Ca-sensitizing drug with combined positive inotropic and vasodilatory effects that offers new therapeutic possibilities in patients with severe heart failure. Compared with other inotropic agents, animal studies demonstrated that levosimendan does not impair left ventricular diastolic function.
OBJECTIVE: We sought to evaluate the effects of levosimendan on left ventricular diastolic function, using conventional transmitral Doppler and Doppler tissue imaging parameters, in patients with anterior acute myocardial infarction undergoing primary angioplasty.
METHODS: After a successful primary angioplasty, we randomized 52 consecutive patients with anterior acute myocardial infarction to levosimendan or placebo infusion and analyzed the diastolic function using conventional transmitral Doppler flow and Doppler tissue imaging at mitral annulus.
RESULTS: At 24 hours after the index intervention, patients treated with levosimendan (n = 26) showed a significant reduction of the isovolumetric relaxation time (114.6 +/- 15.1-69.2 +/- 5.6 milliseconds; P = .001) and the ratio between the early diastolic flow and early tissue velocity (E/E') (21.4 +/- 10.7-12.8 +/- 7.3; P = .04), and a significant increase of the ratio between the early and late diastolic flow (E/A) (0.86 +/- 0.33-1.52 +/- 0.88; P = .03) and E' (6.4-7.9 cm/s; P = .001). On the other hand, only a significant increase in E/A ratio (0.97 +/- 0.32-1.64 +/- 0.51; P = .002) was observed in the placebo group (n = 26).
CONCLUSIONS: Levosimendan, after primary angioplasty in patients with anterior acute myocardial infarction, appears to improve the Doppler echocardiographic parameters of left ventricular diastolic function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16455421     DOI: 10.1016/j.echo.2005.08.016

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  7 in total

Review 1.  [Role of Levosimendan in intensive care treatment of myocardial insufficiency].

Authors:  S Rehberg; C Ertmer; H Van Aken; M Lange; K Bröking; A Morelli; M Westphal
Journal:  Anaesthesist       Date:  2007-01       Impact factor: 1.041

2.  The Use of Levosimendan after Out-of-Hospital Cardiac Arrest and Its Association with Outcome-An Observational Study.

Authors:  Susanne Rysz; Malin Jonsson Fagerlund; Johan Lundberg; Mattias Ringh; Jacob Hollenberg; Marcus Lindgren; Martin Jonsson; Therese Djärv; Per Nordberg
Journal:  J Clin Med       Date:  2022-05-06       Impact factor: 4.964

3.  Analysis of the influences of short-term levosimendan exposure on oxidant/antioxidant status and trace-element levels in the physiological status of the thoracic aorta of rats.

Authors:  Cemalettin Aydin; Yasin Ay; Halil Basel; Servet Kavak; Bekir Inan; Hava Bektaş; Hasan Ali Gümrükçüoğlu; Hasan Ekim; Halit Demir
Journal:  J Membr Biol       Date:  2012-07-29       Impact factor: 1.843

Review 4.  Use of levosimendan in patients with ischemic heart disease following mechanical reperfusion.

Authors:  Ibrahim Halil Kurt
Journal:  Surg Today       Date:  2009-04-30       Impact factor: 2.549

Review 5.  Haemodynamic Balance in Acute and Advanced Heart Failure: An Expert Perspective on the Role of Levosimendan.

Authors:  Piergiuseppe Agostoni; Dimitrios T Farmakis; Jose M García-Pinilla; Veli-Pekka Harjola; Kristjan Karason; Dirk von Lewinski; John Parissis; Piero Pollesello; Gerhard Pölzl; Alejandro Recio-Mayoral; Alexander Reinecke; Patrik Yerly; Endre Zima
Journal:  Card Fail Rev       Date:  2019-11-04

6.  Levosimendan: a cardiovascular drug to prevent liver ischemia-reperfusion injury?

Authors:  Peter Onody; Rita Stangl; Andras Fulop; Oliver Rosero; David Garbaisz; Zsolt Turoczi; Gabor Lotz; Zoltan Rakonczay; Zsolt Balla; Viktor Hegedus; Laszlo Harsanyi; Attila Szijarto
Journal:  PLoS One       Date:  2013-09-11       Impact factor: 3.240

7.  Effect of Levosimendan Compared to Conventional Inotropic Agents on Hemodynamics and Outcome in Patient with Poor LV Function Undergoing Cardiac Surgery.

Authors:  Mahmoud Khaled; Ahmad Naem Almogy; Mohammed Shehata; Fahim Ragab; Khaled Zeineldin
Journal:  Open Access Maced J Med Sci       Date:  2019-08-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.